These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34535974)

  • 21. Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease.
    Wang Y; Yang J; Li H; Wang X; Zhu L; Fan M; Wang X
    PLoS One; 2013; 8(1):e54296. PubMed ID: 23342124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques.
    Hayashi T; Wakao S; Kitada M; Ose T; Watabe H; Kuroda Y; Mitsunaga K; Matsuse D; Shigemoto T; Ito A; Ikeda H; Fukuyama H; Onoe H; Tabata Y; Dezawa M
    J Clin Invest; 2013 Jan; 123(1):272-84. PubMed ID: 23202734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.
    Sortwell CE; Collier TJ; Sladek JR
    J Comp Neurol; 1998 Oct; 399(4):530-40. PubMed ID: 9741481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
    Datta I; Bhonde R
    Cell Biol Int; 2012 Jul; 36(7):617-24. PubMed ID: 22417707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.
    Jiaming M; Niu C
    Neurol Sci; 2015 Feb; 36(2):281-7. PubMed ID: 25159816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.
    Shall G; Menosky M; Decker S; Nethala P; Welchko R; Leveque X; Lu M; Sandstrom M; Hochgeschwender U; Rossignol J; Dunbar G
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.
    Parga JA; García-Garrote M; Martínez S; Raya Á; Labandeira-García JL; Rodríguez-Pallares J
    Mol Neurobiol; 2018 Jun; 55(6):4763-4776. PubMed ID: 28717970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
    Bartlett LE; Mendez I
    Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of Wharton's jelly-derived Mesenchymal Stromal Cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson's disease.
    Jalali MS; Saki G; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Sarkaki A
    J Chem Neuroanat; 2021 Apr; 113():101921. PubMed ID: 33600923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
    Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
    J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
    Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
    Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
    Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
    J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease.
    Deng X; Liang Y; Lu H; Yang Z; Liu R; Wang J; Song X; Long J; Li Y; Lei D; Feng Z
    PLoS One; 2013; 8(12):e80880. PubMed ID: 24312503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
    Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
    J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Sertoli Cells on Xenotransplantation and Allotransplantation of Ventral Mesencephalic Tissue in a Rat Model of Parkinson's Disease.
    Jhao YT; Chiu CH; Chen CF; Chou TK; Lin YW; Ju YT; Wu SC; Yan RF; Shiue CY; Chueh SH; Halldin C; Cheng CY; Ma KH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31718058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis.
    Lian C; Huang Q; Zhong X; He Z; Liu B; Zeng H; Xu N; Yang Z; Liao C; Fu Z; Guo H
    FASEB J; 2021 Jul; 35(7):e21748. PubMed ID: 34152016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional dopaminergic neurons derived from human chorionic mesenchymal stem cells ameliorate striatal atrophy and improve behavioral deficits in Parkinsonian rat model.
    Ebrahimi V; Eskandarian Boroujeni M; Aliaghaei A; Abdollahifar MA; Piryaei A; Haghir H; Sadeghi Y
    Anat Rec (Hoboken); 2020 Aug; 303(8):2274-2289. PubMed ID: 31642188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
    Glavaski-Joksimovic A; Virag T; Mangatu TA; McGrogan M; Wang XS; Bohn MC
    J Neurosci Res; 2010 Sep; 88(12):2669-81. PubMed ID: 20544825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.